KATELYN LOMAX: Open Payments
NPI 1669013942 · LITTLE ROCK, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,251 in 73 payments from 17 companies in 2025. Trend: 2023 $823 · 2024 $1,379 · 2025 $2,251
Food & beverage: $1,883Travel & lodging: $369
| Company | Payments | Amount |
|---|---|---|
| ABIOMED | 17 | $971 |
| CVRx, Inc. | 6 | $320 |
| Alnylam Pharmaceuticals Inc. | 10 | $147 |
| Abbott Laboratories | 9 | $144 |
| PFIZER INC. | 9 | $141 |
| AtriCure, Inc. | 1 | $83 |
| Actelion Pharmaceuticals US, Inc. | 3 | $72 |
| Daxor Corporation | 1 | $60 |
| E.R. Squibb & Sons, L.L.C. | 3 | $59 |
| Merck Sharp & Dohme LLC | 3 | $49 |
Products named: Barostim Neo System, AMVUTTRA, VYNDAQEL, CARDIOMEMS, SYNERGY ABLATION SYSTEM, BVA-100, CAMZYOS, VERQUVO.
Industry payments across AR — which companies pay providers there.
